PUMA BIOTECHNOLOGY, INC. Number of Operating Segments
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Number of Operating Segments of 100.00% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2025-11-06
- PUMA BIOTECHNOLOGY, INC. number of operating segments for the quarter ending 2021-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. number of operating segments for the quarter ending 2020-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. number of operating segments for the quarter ending 2019-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. number of operating segments for the quarter ending 2018-03-31 was 1.00 Segment.
- PUMA BIOTECHNOLOGY, INC. number of operating segments for fiscal 2020 was 1.00 Segment, a 0.00% change from fiscal 2019.
- PUMA BIOTECHNOLOGY, INC. number of operating segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.
- PUMA BIOTECHNOLOGY, INC. number of operating segments for fiscal 2018 was 1.00 Segment, a 0.00% change from fiscal 2017.
- PUMA BIOTECHNOLOGY, INC. number of operating segments for fiscal 2017 was 1.00 Segment.
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2021-06-30 | 1.00 Segment 10-Q · filed 2021-08-05 | |||
| 2021-03-31 | 1.00 Segment 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 1.00 Segment 10-K · filed 2021-03-01 | |||
| 2020-09-30 | 1.00 Segment 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 1.00 Segment 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | 1.00 Segment 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-02-28 | |||
| 2019-09-30 | 1.00 Segment 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 1.00 Segment 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | 1.00 Segment 10-Q · filed 2019-05-10 | |||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-03-01 | |||
| 2018-09-30 | 1.00 Segment 10-Q · filed 2018-11-05 | |||
| 2018-06-30 | 1.00 Segment 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | 1.00 Segment 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | 1.00 Segment 10-K · filed 2018-03-09 |
pure
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2025-09-30 | 100.00% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 100.00% 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 100.00% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 100.00% 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 100.00% 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 100.00% 10-Q · filed 2024-08-01 | |||
| 2024-03-31 | 100.00% 10-Q · filed 2024-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |